Evaluating Carter's: Insights From 4 Financial Analysts
Portfolio Pulse from Benzinga Insights
Carter's (NYSE:CRI) received mixed ratings from 4 analysts, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target is $75.75, indicating a 10.99% increase from the previous target. Analysts from UBS, Evercore ISI Group, Wedbush, and Citigroup adjusted their price targets, reflecting changes in market conditions and company performance. Despite a -3.29% decline in revenue over the past 3 months, Carter's demonstrates strong financial health with an 8.19% net margin and an 8.31% ROE. The company's debt-to-equity ratio is below industry average, suggesting conservative financial management.
February 28, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Carter's received mixed analyst ratings with an updated average 12-month price target of $75.75, reflecting a positive outlook despite recent revenue decline.
The mixed analyst ratings with a majority leaning towards neutral or positive adjustments in price targets suggest a cautiously optimistic outlook for Carter's. The increase in the average price target indicates expectations of growth or recovery. Despite the revenue decline, the company's strong financial health metrics such as net margin, ROE, and a conservative debt-to-equity ratio support a positive short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100